Twenty-three patients were diagnosed as PV of which 21 cases (91.3%) were reported to have positive JAK2 V617F mutation, and no mutation (triple-negative) was observed in two cases (8.7%) (Figure 1). Here, JAK2 is linked to acquired polycythemia vera.